Title: |
|
Average Annual Total Expenses, Total Utilization, and Sources of Payment for Outpatient Prescription Opioids in the U.S. Adult Civilian Noninstitutionalized Population, 2021-2022 |
Description: |
|
This Statistical Brief investigates opioid utilization and expenditures among adults (ages 18 and older) within the U.S. civilian non-institutionalized population. Utilizing data from the Medical Expenditure Panel Survey (MEPS) Household Component (HC), we provide estimates of total expenses, total fills, and sources of payment for outpatient prescription opioids for pain. Additionally, the brief presents the same measures for the top five opioid products ranked by total expenses in 2021-2022: Oxycodone, hydrocodone, tramadol, morphine, and codeine. |
Author(s): |
|
Xue Wu, PhD, Asako S. Moriya, PhD, and G. Edward Miller, PhD |
Agency: |
|
Rockville (MD): Agency for Healthcare Research and Quality |